Pet humanization isn't a buzzword anymore — it's a supply chain reality. Innova Market Insights reports that demand for pet food addressing specific health needs is now outpacing the industry's ability to supply it. Pet parents read labels like their own: clean, transparent, science-backed. Immune support is a top priority for aging pets an
Yeast Beta‑Glucan Market to Nearly Double by 2034: Science‑Backed Immunity for Modern Supplements
The yeast beta-glucan market is projected to nearly double by 2034 — from ~$264M in 2026 to ~$498M, an 8.2% CAGR. Why? Immunity remains the #1 reason consumers buy supplements, and brands are moving beyond generic formulas toward science-backed ingredients with real mechanism stories. That's where yeast beta-glucan (1,3/1,6) fits perfectly.
Immunity Is Top Priority for Pet Parents: Yeast Beta‑Glucan for Science‑Backed Functional Pet Treats
Pet parents now read ingredient labels like their own supplement bottles — and immunity has moved to the top of the list. Big CPG moving into premium wellness (hello, P&G × Thorne) shows the same logic reaching the pet aisle: consumers want functional treats backed by science, not just clever marketing. ️ That's where yeast beta-gluc